Blood and Blood Components Market: By Product, By Collection Method, By End-user, and Geography

Blood and Blood Components Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Whole Blood, Red Blood Cells, Platelets, Plasma, and Others), By Collection Method (Manual Method and Apheresis), By End-user (Hospitals, Ambulatory Surgical Centers, Blood Banks, and Others), and Region

Blood and Blood Components Market size was valued at US$ 13,732.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2024 to 2030. Blood and blood components are essential for various medical treatments, including surgeries, trauma care, and haematological disorders. The market encompasses whole blood, red blood cells, platelets, plasma, and other blood-derived products. These components play crucial roles in transfusion medicine, with applications ranging from treating anaemia to supporting patients undergoing chemotherapy. The market's growth is driven by factors such as the increasing prevalence of chronic diseases, rising surgical procedures, and advancements in blood collection and processing technologies.

According to the World Health Organization, approximately 118.5 million blood donations are collected globally each year, yet there remains a significant gap between supply and demand, particularly in developing countries. The COVID-19 pandemic has further highlighted the importance of a robust blood supply chain, with many regions experiencing shortages due to reduced donations and increased demand for convalescent plasma. This has spurred innovations in blood collection, storage, and distribution methods. However, the market faces challenges such as the risk of transfusion-transmitted infections, stringent regulatory requirements, and the high cost of blood screening and processing. These factors can limit access to safe blood products, especially in resource-constrained settings

Blood and Blood Components Market Key Developments:
  • In March 2022, the U.S. FDA approved Bluebird Bio's Zynteglo, the first gene therapy for beta-thalassemia, potentially reducing the need for regular blood transfusions in affected patients.
  • In August 2023, Terumo Blood and Cell Technologies (Terumo BCT) announces U.S. Food and Drug Administration (FDA) clearance of the Reveos Automated Whole Blood Processing System, the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.

Blood and Blood Components Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

2.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Blood and Blood Components Market Dynamics

The blood and blood components market is influenced by a complex interplay of medical, technological, and socioeconomic factors. The growing prevalence of blood disorders, such as leukaemia and thalassemia, drives demand for transfusion products. The American Cancer Society estimated 60,530 new leukaemia cases in the U.S. in 2020, many requiring blood transfusions as part of their treatment. Simultaneously, the ageing global population contributes to increased demand, as older individuals are more likely to require blood transfusions for various medical procedures. Technological advancements are reshaping the market landscape, with innovations like pathogen reduction technologies enhancing blood product safety. The plasma-derived products segment, a key component of the market, is experiencing rapid growth due to rising applications in treating immune deficiencies and neurological disorders. However, the market faces significant challenges, including the persistent risk of transfusion reactions and the development of alternatives like synthetic blood substitutes. Ethical considerations surrounding blood donation and the need for culturally sensitive approaches to encourage donation in diverse populations also impact market dynamics. Additionally, the global disparities in access to safe blood products highlight the need for improved infrastructure and blood management systems, particularly in low- and middle-income countries.

Blood and Blood Components Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 13,732.9 million

Market CAGR

2.9%

By Product

  • Whole Blood
  • Red Blood Cells
  • Platelets
  • Plasma
  • Others

By Collection Method

  • Manual Method
  • Apheresis

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Blood Banks
  • Others

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The blood and blood components market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.

Download Free Sample Report

Frequently Asked Questions

The global blood and blood components market size was valued at US$ 13,732.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.9% from 2023 to 2030.

The global blood and blood components market is segmented based on product, collection method, end-user, and geography.

The leading players in the market include Becton, Dickinson and Company, Terumo Corporation, Grifols S.A., CSL Limited, and Haemonetics Corporation, among others.

North America dominated the Blood and blood components market due to advanced healthcare systems, high healthcare expenditure, and the presence of major industry players.

The market is primarily driven by factors such as the increasing prevalence of chronic diseases, the rising number of surgical procedures, technological advancements in blood collection and processing methods, and growing awareness about blood donation.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Blood and Blood Components Market Introduction 
2.1.Global Blood and Blood Components Market  - Taxonomy
2.2.Global Blood and Blood Components Market  - Definitions
2.2.1.Product
2.2.2.Collection Method
2.2.3.End User
2.2.4.Region
3.Global Blood and Blood Components Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Blood and Blood Components Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Blood and Blood Components Market  By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Whole Blood
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Red Blood Cells
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Platelets
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Plasma
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6.Global Blood and Blood Components Market  By Collection Method, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Manual Method
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Apheresis
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Blood and Blood Components Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Ambulatory Surgical Centers
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Blood Banks
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Blood and Blood Components Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Whole Blood
9.1.2.Red Blood Cells
9.1.3.Platelets
9.1.4.Plasma
9.1.5.Others
9.2.  Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Manual Method
9.2.2.Apheresis
9.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Ambulatory Surgical Centers
9.3.3.Blood Banks
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Whole Blood
10.1.2.Red Blood Cells
10.1.3.Platelets
10.1.4.Plasma
10.1.5.Others
10.2.  Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Manual Method
10.2.2.Apheresis
10.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Ambulatory Surgical Centers
10.3.3.Blood Banks
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Whole Blood
11.1.2.Red Blood Cells
11.1.3.Platelets
11.1.4.Plasma
11.1.5.Others
11.2.  Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Manual Method
11.2.2.Apheresis
11.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Ambulatory Surgical Centers
11.3.3.Blood Banks
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Whole Blood
12.1.2.Red Blood Cells
12.1.3.Platelets
12.1.4.Plasma
12.1.5.Others
12.2.  Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Manual Method
12.2.2.Apheresis
12.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Ambulatory Surgical Centers
12.3.3.Blood Banks
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Blood and Blood Components Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Whole Blood
13.1.2.Red Blood Cells
13.1.3.Platelets
13.1.4.Plasma
13.1.5.Others
13.2.  Collection Method Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Manual Method
13.2.2.Apheresis
13.3.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Ambulatory Surgical Centers
13.3.3.Blood Banks
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Becton, Dickinson and Company
14.2.2.Terumo Corporation
14.2.3.Grifols S.A.
14.2.4.CSL Limited
14.2.5.Haemonetics Corporation
14.2.6.Fresenius Kabi AG
14.2.7.Biomat S.A.
14.2.8.Octapharma AG
14.2.9.LFB Group
14.2.10.Kedrion S.p.A.
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Becton, Dickinson and Company
  • Terumo Corporation
  • Grifols S.A.
  • CSL Limited
  • Haemonetics Corporation
  • Fresenius Kabi AG
  • Biomat S.A.
  • Octapharma AG
  • LFB Group
  • Kedrion S.p.A.

Related Industry Reports